LEISGUARD 5 mg/ml oral suspension for dogs
LEISGUARD 5 mg/ml oral suspension for dogs
Authorised
- Domperidone
Product identification
Medicine name:
LEISGUARD 5 mg/ml oral suspension for dogs
LEISGUARD 5MG/ML πόσιμο εναιώρημα για σκύλους
Active substance:
- Domperidone
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Domperidone5.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51DX06
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Package description:
- box containing 4 bottles of 60 ml and 2 syringes
- box containing 3 bottles of 60 ml and 2 syringes
- box containing 2 bottles of 60 ml and 2 syringes
- box containing 1 bottle of 60 ml and 2 syringes
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Divasa Farmavic S.A.
- Sincrofarm S.L.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 2027/11-01-2017/K-0191801
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0170/001
Concerned member states:
-
Cyprus
-
Greece
-
Italy
-
Portugal
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
